0001209191-19-036764.txt : 20190613 0001209191-19-036764.hdr.sgml : 20190613 20190613161600 ACCESSION NUMBER: 0001209191-19-036764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190611 FILED AS OF DATE: 20190613 DATE AS OF CHANGE: 20190613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danziger Asaf CENTRAL INDEX KEY: 0001654435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 19896276 MAIL ADDRESS: STREET 1: 5 NACHUM CHAT ST. CITY: TIRAT HACARMEL STATE: L3 ZIP: 5112302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-11 0 0001645113 NovoCure Ltd NVCR 0001654435 Danziger Asaf C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Ordinary Shares 2019-06-11 4 M 0 16835 14.37 A 275146 D Ordinary Shares 2019-06-11 4 S 0 15985 54.71 D 259161 D Ordinary Shares 2019-06-11 4 S 0 850 55.425 D 258311 D Ordinary Shares 2019-06-12 4 M 0 30436 14.37 A 288747 D Ordinary Shares 2019-06-12 4 S 0 12233 54.886 D 276514 D Ordinary Shares 2019-06-12 4 S 0 18203 55.735 D 258311 D Options to Buy Ordinary Shares 14.37 2019-06-11 4 M 0 16835 0.00 D 2025-02-23 Ordinary Shares 16835 220774 D Options to Buy Ordinary Shares 14.37 2019-06-12 4 M 0 30436 0.00 D 2025-02-23 Ordinary Shares 30436 190338 D Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 15,985 shares in multiple trades at prices ranging from $54.37 to $55.35. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 850 shares in multiple trades at prices ranging from $55.41 to $55.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 12,233 shares in multiple trades at prices ranging from $54.39 to $55.38. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 18,203 shares in multiple trades at prices ranging from $55.40 to $56.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested and currently exercisable as of the date hereof. By: /s/ Todd Longsworth, Attorney in fact for Asaf Danziger 2019-06-13